Parkinsn's Email List Message

Posting to the Parkinsn List is a benefit of Subscription


[Message Prev][Message Next][Thread Prev][Thread Next][Message Index][Thread Index]

PMID: 10727711: Protective effect of riluzole in the MPTP model of PD


The protective effect of riluzole in the MPTP model of Parkinson's disease in 
mice
is not due to a decrease in MPP(+) accumulation.


Riluzole, has previously been shown to be protective in animal models of 
Parkinson's disease in vivo.

In the present study the effects of riluzole on the intrastriatal formation and 
accumulation of MPP(+), after i.p. injection of MPTP were tested in mice, using 
two different experimental protocols.

In the first protocol, mice were treated with a single dose (15 mg/kg i.p.) of 
MPTP and MPP(+) accumulation was measured 30 min, 1 h and 3 h after the 
injection of the toxin.

Riluzole (10 mg/kg p.o.), administered 30 min before MPTP, did not modify the 
accumulation kinetic of MPP(+).

Contrarily to riluzole, a single dose of 50 mg/kg p.o. of 7-nitroindazole 
(7-NI), a non-selective non hypertensive inhibitor of nitric oxide synthase 
(NOS), significantly decreased MPP(+) levels.

In the second protocol, consisting of 3 injections of MPTP (15 mg/kg i.p.), 
riluzole, administered 4 times at the dose of 5 mg/kg p.o., had no effect on 
MPP(+) levels.

The protective effect of repeated treatments of riluzole and 7-NI against 
MPTP-induced depletion of dopamine (DA) is also reported.

Our data obtained with 7-NI (in agreement with previous studies reported by 
others) suggest that a part of the protection observed with this NOS inhibitor 
is probably due to in vivo inhibition of monoamine oxidase-B (MAO-B).

That riluzole does not modify MPP(+) accumulation demonstrates that its 
protective effect against MPTP toxicity was not due to an in vivo interference 
with MPTP metabolism.


Neuropharmacology 2000 May  1;39(6):1016-1020
Boireau A, Dubedat P, Bordier F, Imperato A, Moussaoui S
Rhone-Poulenc Rorer S.A., Centre de Recherche de Vitry-Alfortville, 
Vitry-sur-Seine Cedex, France

PMID: 10727711

<>

janet paterson
53 now / 41 dx / 37 onset
a new voice: 
613 256 8340 PO Box 171 Almonte Ontario Canada K0A 1A0


Parkinsn's List Subject Index

Parkinsn's List Thread Index

Parkinsn's Archive Treasures Doctors, students, patients and caregivers find current Parkinson's information such as the Algorithm, Caregivers Handbook, and talks by respected Movement Disorder Specialists.

Mail converted by MHonArc 2.6.10
Site Hosting donated by He.net
&
Grant from The Parkinson Alliance